- Home
- ATRA vs BEAT Comparison
ATRA vs BEAT Comparison
Compare ATRA & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- BEAT
- Stock Information
- Founded
- ATRA 2012
- BEAT 2015
- Country
- ATRA United States
- BEAT United States
- Employees
- ATRA N/A
- BEAT N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- ATRA Health Care
- BEAT Technology
- Exchange
- ATRA Nasdaq
- BEAT Nasdaq
- Market Cap
- ATRA 65.1M
- BEAT 74.1M
- IPO Year
- ATRA 2014
- BEAT 2021
- Fundamental
- Price
- ATRA $9.44
- BEAT $2.26
- Analyst Decision
- ATRA Buy
- BEAT Buy
- Analyst Count
- ATRA 6
- BEAT 1
- Target Price
- ATRA $25.70
- BEAT $8.00
- AVG Volume (30 Days)
- ATRA 436.6K
- BEAT 110.4K
- Earning Date
- ATRA 03-27-2025
- BEAT 03-19-2025
- Dividend Yield
- ATRA N/A
- BEAT N/A
- EPS Growth
- ATRA N/A
- BEAT N/A
- EPS
- ATRA N/A
- BEAT N/A
- Revenue
- ATRA $100,439,000.00
- BEAT N/A
- Revenue This Year
- ATRA $1,339.87
- BEAT N/A
- Revenue Next Year
- ATRA N/A
- BEAT N/A
- P/E Ratio
- ATRA N/A
- BEAT N/A
- Revenue Growth
- ATRA 2111.34
- BEAT N/A
- 52 Week Low
- ATRA $5.40
- BEAT $1.35
- 52 Week High
- ATRA $28.75
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- ATRA 44.94
- BEAT 47.78
- Support Level
- ATRA $8.02
- BEAT $2.02
- Resistance Level
- ATRA $9.10
- BEAT $2.44
- Average True Range (ATR)
- ATRA 1.12
- BEAT 0.14
- MACD
- ATRA -0.02
- BEAT 0.04
- Stochastic Oscillator
- ATRA 45.13
- BEAT 50.00
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.